WHO Backs Trials of Two Vaccines Targeting Ebola Strain Behind DRC Outbreak
The World Health Organization has approved clinical trials of two vaccines designed to protect against the Bundibugyo strain of Ebola. The trials will be led by the Democratic Republic of the Congo’s National Institute for Biomedical Research, with support from WHO and partner organisations.
Use The App To Win ₦1m
Stories are shared by community members. This article does not represent the official view of NaijaWorld — the author is solely responsible for its content.